J

James Ciarcia

Yale New Haven Hospital

Publishes on Epilepsy research and treatment, Blood Pressure and Hypertension Studies, Functional Brain Connectivity Studies. 8 papers and 685 citations.

8Publications
685Total Citations

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

Increased Cortical GABA Concentrations in Depressed Patients Receiving ECT
Gerard Sanacora, Graeme F. Mason, Douglas L. Rothman et al.|American Journal of Psychiatry|2003
Cited by 512

OBJECTIVE: Reduced gamma-aminobutyric acid (GABA) concentrations have been reported in the plasma, CSF, and cortex of depressed subjects. Of interest is that ECT, one of the most effective treatments for severe refractory depression, produces considerable anticonvulsant effects that may be related to increased GABAergic transmission. The purpose of this study was to determine if cortical GABA concentrations increase following a course of ECT. METHOD: Occipital cortex GABA concentrations in eight depressed patients were measured by using proton magnetic resonance spectroscopy before and after a course of ECT. RESULTS: A significant increase in occipital cortex GABA concentrations was seen following ECT treatment of depression. CONCLUSIONS: Occipital cortex GABA concentrations increase two-fold following ECT. This suggests possible GABAergic involvement in ECT's mechanism of anticonvulsant and antidepressant actions.

Biofeedback and Hypertension
James Ciarcia, Hoyle Leigh|Psychotherapy and Psychosomatics|2010
Cited by 3

A review of the history and recent directions in the treatment of essential hypertension by direct biofeedback is presented. Current instrumentation and techniques as well as the status of biofeedback in the treatment of hypertension and the follow-up of previous studies is presented. Given the current uncertain status of biofeedback and behavioral treatment of hypertension, the authors present speculation of putative subgroups of essential hypertensives with respective biochemical markers and possible selective behavioral treatments for these respective subgroups of central nervous system hypertensives.